Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MPA vs LNG-IUS in Early-stage Endometrioid Carcinoma
NCT05565573Phase 3Unknown
- Sponsor
- Hua Medicine
- Start
- Nov 2022
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of avatrombopag in endometrial carcinoma, Atypical endometrial hyperplasia (AEH), sponsored by Hua Medicine. Status: unknown.
02
Drugs
avatrombopag
03
Conditions
endometrial carcinomaAtypical endometrial hyperplasia (AEH)
Beyond the preview
Go deeper on NCT05565573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05565573.